European Committee Releases Positive Opinion on Cystic Fibrosis Drug for Orphan Medicinal Product
Cystic Fibrosis, News
Canada-based biotech Arch Biopartners announced the European Medicines Agency’s (EMA) Committee for Orphan Medicinal Products (COMP) has released a positive recommendation for the company’s treatment for infections linked to cystic fibrosis (CF). The ... Read more